MEASuRE: Metreleptin Effectiveness And Safety Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAmryt Pharma
About this trial
The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.
Eligibility criteria
Qualifiers
Patients treated with metreleptin through commercial supply at the time or before enrolment into registry
Patients who provide a written consent
Patient coming off metreleptin clinical studies and continuing or restarting treatment with metreleptin through commercial supply
Disqualifiers
None
Trial design
Treatments tested in this trial
- Metreleptin
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov